Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y ▲ |
|---|---|---|---|---|---|---|---|
| Inotiv Inc. | -1.590% | -6.436% | -59.787% | -19.231% | 15.244% | - | - |
| Akebia Therapeutics Inc. | 0.160% | -1.887% | -27.610% | 50.907% | 6.485% | -52.366% | - |
| Fibrogen Inc. | -0.330% | -11.959% | -56.606% | -93.776% | 10.000% | -94.833% | - |
| Bluebird Bio Inc. | 3.870% | -8.293% | -26.681% | -77.794% | -29.916% | -96.513% | - |
| TG Therapeutics Inc. | -0.730% | -2.811% | -10.657% | -44.146% | -21.644% | -64.996% | - |
| Nektar Therapeutics | 12.290% | 4.329% | 44.554% | 77.755% | 146.738% | -92.634% | - |
| Sage Therapeutics Inc. | 2.860% | 2.037% | -26.580% | -70.428% | -36.125% | -80.292% | - |
| Biodelivery Sciences | -0.980% | - | - | - | - | - | - |
| Jaguar Health Inc. | 15.330% | 13.936% | 105.644% | 114.322% | 10.993% | -99.945% | - |
| ImmunityBio Inc. | 22.750% | 38.932% | 37.320% | 170.315% | 45.466% | -56.894% | - |
| X4 Pharmaceuticals, Inc. | 1.930% | -7.555% | -12.880% | -19.926% | 39.615% | - | - |
| Viking Therapeutics Inc | 0.090% | 16.667% | -8.439% | 259.234% | 297.140% | 1244.173% | - |
| Insulet Corp. | 0.610% | -1.922% | -3.591% | -46.654% | -22.877% | -39.169% | - |
| Fate Therapeutics Inc. | -0.060% | -21.195% | -47.838% | -33.000% | -0.253% | -95.323% | - |
| Amneal Pharmaceuticals Inc | 9.900% | - | - | - | - | - | - |
| Cocrystal Pharma Inc. | -0.720% | -0.719% | 1.471% | -37.838% | -10.968% | -88.384% | - |
| Twist Bioscience Corp | -1.360% | 12.395% | -7.385% | 160.106% | -14.679% | -74.726% | - |
| Brainstorm Cell | -5.760% | -2.456% | -5.429% | -82.011% | 114.009% | -83.450% | - |
| Ardelyx Inc. | -0.300% | -1.640% | -11.302% | 48.049% | 3.737% | -18.973% | - |
| Actinium Pharmaceuticals Inc. | 6.600% | 0.156% | -12.449% | -19.563% | 42.367% | -3.233% | - |
| Abeona Therapeutics Inc. | 14.380% | -56.901% | -54.328% | 9.052% | -35.032% | -91.137% | - |
| Gritstone Oncology Inc | 0.200% | 11.232% | -68.609% | -64.385% | -58.692% | -90.478% | - |
| Salarius Pharmaceuticals Inc. | -1.840% | 1.429% | 0.472% | -70.417% | -23.243% | -98.377% | -99.993% |
| SELLAS Life Sciences Group Inc | -15.000% | -5.028% | 45.923% | 3.343% | 39.487% | -80.571% | -99.630% |
| Sangamo Therapeutics Inc. | 4.980% | 1.166% | -21.366% | -63.457% | -15.528% | -95.223% | -95.507% |
| Esperion Therapeutis.Inc. | 1.040% | -2.985% | -28.134% | 55.668% | -38.275% | -92.196% | -95.406% |
| Genfit S.A. | -1.090% | 0.475% | -5.232% | -14.440% | -12.067% | -13.483% | -85.986% |
| aTyr Pharma Inc | 0.690% | -2.027% | -20.765% | -17.614% | 12.403% | -55.793% | -81.604% |
| Pacific Biosciences of California Inc. | 13.200% | -5.523% | -60.493% | -85.660% | -85.277% | -95.021% | -79.141% |
| Enzo Biochem. Inc. | - | -2.000% | -16.239% | -57.018% | -20.325% | -63.704% | -68.083% |